We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Effects of Folic Acid Plus Vitamin B12 vs Placebo in Myocardial Infarction Survivors

Joel B. Mason, MD; John A. Baron, MD
JAMA. 2010;304(16):1783-1784. doi:10.1001/jama.2010.1473.
Text Size: A A A
Published online


To the Editor: Past observations have raised a concern that habitual intake of supraphysiological doses of folic acid might enhance the risk of cancer among persons with precancerous or cancerous lesions. Cancers of the colorectum and prostate have been particularly implicated. Although the primary purpose of the SEARCH trial1 was to examine whether folic acid and vitamin B12 supplementation would diminish cardiovascular events over 6 to 7 years of follow-up, information on incident cancers was collected as a secondary end point. A relative increase of 7% in overall cancer risk occurred with the intervention (rate ratio [RR], 1.07; 95% confidence interval [CI], 0.96-1.19); for colorectal cancer, the RR was 0.95 (95% CI, 0.71-1.27) and for prostate cancer, 1.18 (95% CI, 0.94-1.49). The authors concluded that the results “ . . . indicate that folic acid supplementation has no significant adverse effects on cancer. . . . ” We believe that the data in this study do not justify that conclusion.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




October 27, 2010
Jane Armitage, FRCP; Robert Clarke, FRCP; Rory Collins, FRCP
JAMA. 2010;304(16):1783-1784. doi:10.1001/jama.2010.1474.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.